Liposomes--problems and promise as selective drug carriers

Cediranib in addition to chemotherapy for women with relapsed platinum-sensitive ovarian cancer (ICON6): overall survival results of a phase III randomised trial.

ESMO open·2021

A decade of clinical development of PARP inhibitors in perspective.

Annals of oncology : official journal of the European Society for Medical Oncology·2019

Clinical Outcome of Patients with Advanced Biliary Tract Cancer in a Dedicated Phase I Unit.

Clinical oncology (Royal College of Radiologists (Great Britain))·2017

The Influence of Donor and Recipient Gender Incompatibility on Corneal Transplant Rejection and Failure.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2016

An Adaptive Study to Determine the Optimal Dose of the Tablet Formulation of the PARP Inhibitor Olaparib.

Targeted oncology·2016

Progress in the treatment of ovarian cancer-lessons from homologous recombination deficiency-the first 10 years.

Annals of oncology : official journal of the European Society for Medical Oncology·2016

Vinorelbine and low-dose cyclophosphamide as maintenance therapy in the treatment of Ewing sarcoma rationale for the international INTER-EWING-1 trial for Ewing sarcoma patients.

Cancer treatment reviews·2026

Is Cytoreductive surgery for unresectable colorectal liver metastases able to improve patient outcome? Results of a pilot prospective study.

Cancer treatment reviews·2026

Chondrosarcoma: A comprehensive review of tumor biology, clinical behavior, and therapeutic advances.

Cancer treatment reviews·2026

Pharmacological prevention of second primary cancers: From chemoprevention to precision cancer interception.

Cancer treatment reviews·2026

Understanding extrapulmonary neuroendocrine carcinomas: Survival, prognosis, and patient quality of life.

Cancer treatment reviews·2026

Comparative analysis of patient-derived organoids and patient-derived xenografts as avatar models for predicting response to anti-cancer therapy.

Cancer treatment reviews·2026

Stimulation of the STING pathway leads to inhibition of HBV replication: insights into the role of hepatic macrophages.

The Journal of infectious diseases·2026

Erratum: Evaluating the effectiveness of nicardipine prolonged-release implants in patients with subarachnoid hemorrhage: a meta-analysis and meta-regression analysis.

Annals of medicine and surgery (2012)·2026

An umbrella review of systematic reviews and meta-analyses evaluating the efficacy and safety of mechanical thrombectomy for acute ischemic stroke.

Annals of medicine and surgery (2012)·2026

Low-power NIR-mediated photothermal and photodynamic therapy as a synergistic strategy against superbugs.

Frontiers in microbiology·2026

Streamlining Genetically Modified Organism Regulatory Classification in UK Gene Therapy Clinical Trials: A UK Pharmacy Perspective.

Human gene therapy·2026

EXPRESS: NSUN6-mediated 5-methylcytosine modification of USP2-AS1 drives Wnt/β-catenin signaling in brain arteriovenous malformations.

Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism·2026

Related Experiment Videos

Liposomes--problems and promise as selective drug carriers

Related Concept Videos

Cediranib in addition to chemotherapy for women with relapsed platinum-sensitive ovarian cancer (ICON6): overall survival results of a phase III randomised trial.

A decade of clinical development of PARP inhibitors in perspective.

Clinical Outcome of Patients with Advanced Biliary Tract Cancer in a Dedicated Phase I Unit.

The Influence of Donor and Recipient Gender Incompatibility on Corneal Transplant Rejection and Failure.

An Adaptive Study to Determine the Optimal Dose of the Tablet Formulation of the PARP Inhibitor Olaparib.

Progress in the treatment of ovarian cancer-lessons from homologous recombination deficiency-the first 10 years.

Vinorelbine and low-dose cyclophosphamide as maintenance therapy in the treatment of Ewing sarcoma rationale for the international INTER-EWING-1 trial for Ewing sarcoma patients.

Is Cytoreductive surgery for unresectable colorectal liver metastases able to improve patient outcome? Results of a pilot prospective study.

Chondrosarcoma: A comprehensive review of tumor biology, clinical behavior, and therapeutic advances.

Pharmacological prevention of second primary cancers: From chemoprevention to precision cancer interception.

Understanding extrapulmonary neuroendocrine carcinomas: Survival, prognosis, and patient quality of life.

Comparative analysis of patient-derived organoids and patient-derived xenografts as avatar models for predicting response to anti-cancer therapy.

Stimulation of the STING pathway leads to inhibition of HBV replication: insights into the role of hepatic macrophages.

Erratum: Evaluating the effectiveness of nicardipine prolonged-release implants in patients with subarachnoid hemorrhage: a meta-analysis and meta-regression analysis.

An umbrella review of systematic reviews and meta-analyses evaluating the efficacy and safety of mechanical thrombectomy for acute ischemic stroke.

Low-power NIR-mediated photothermal and photodynamic therapy as a synergistic strategy against superbugs.

Streamlining Genetically Modified Organism Regulatory Classification in UK Gene Therapy Clinical Trials: A UK Pharmacy Perspective.

EXPRESS: NSUN6-mediated 5-methylcytosine modification of USP2-AS1 drives Wnt/β-catenin signaling in brain arteriovenous malformations.

Related Experiment Videos

Liposomes--problems and promise as selective drug carriers

Related Concept Videos

Related Articles